恩华药业：10月24日召开董事会会议

Group 1 - Enhua Pharmaceutical held its seventh fourth board meeting on October 24, 2025, in Xuzhou, where the third quarter report for 2025 was reviewed [1] - The company reported that it has sold overseas authorizations worth $80 billion in the current year [1] - The secondary market for biopharmaceuticals is experiencing a surge, while the primary market is facing challenges in fundraising [1]